SCHEMBL21855845

SCHEMBL21855845

COC(=O)CCSc1cc(N)nc2[nH]ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GLA P06280 1/20 0.39
▸ GSTP1 P09211 1/20 0.38
▸ GSTM2 P28161 1/20 0.38
▸ JAK2 O60674 2/20 0.36
▸ TP53 P04637 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ NOTUM Q6P988 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ DYRK1A Q13627 1/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ PTGS1 P23219 1/20 0.34
▸ MAPK10 P53779 1/20 0.34
▸ MPO P05164 2/20 0.34
▸ JAK3 P52333 2/20 0.33
▸ PRNP P04156 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ JAK1 P23458 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29505977 1.00 GLA (0.39) GLAGSTP1GSTM2JAK2TP53
SCHEMBL22493827 0.79 NUDT1 (0.47) GSTP1GSTM2JAK2NOTUMKMT2A
SCHEMBL10877599 0.73 TP53 (0.52) TP53ALDH1A1GAAKMT2AMEN1
SCHEMBL10588609 0.68 LMNA (0.47) GSTP1GSTM2ALDH1A1GAAKMT2A
SCHEMBL22493648 0.68 JAK2 (0.40) GSTP1GSTM2JAK2NOTUMKMT2A
SCHEMBL21855875 0.68 CXCR1 (0.44) GSTP1GSTM2JAK2NOTUMJAK3
SCHEMBL29506077 0.68 CXCR1 (0.44) GSTP1GSTM2JAK2NOTUMJAK3
SCHEMBL23663615 0.68 NUDT1 (0.56) GLAJAK2TP53ALDH1A1NOTUM
SCHEMBL31280881 0.68 NUDT1 (0.56) GLAJAK2TP53ALDH1A1NOTUM
SCHEMBL21852192 0.68 GSTP1 (0.42) GSTP1GSTM2ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066357-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2025-02-27 — — US disclosed
US-12187721-B2 Protein tyrosine phosphatase inhibitors ARRAY BIOPHARMA INC. (US) 2025-01-07 — — US disclosed
EP-3867238-B1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC (US) 2023-06-07 — — EP disclosed
EP-3867238-B1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC (US) 2023-06-07 — — EP disclosed
CN-114341124-A Protein tyrosine phosphatase inhibitors ARRAY生物制药公司 2022-04-12 — — CN disclosed
US-20210380582-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2021-12-09 — — US disclosed
US-20210380582-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2021-12-09 — — US disclosed
WO-2020081848-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2020-04-23 — — WO disclosed
WO-2020081848-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2020-04-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066357-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS PPM1A, PPM1F, PPP5C GLA 1252/4885GSTP1 1370/4885GSTM2 2265/4885
US-12187721-B2 Protein tyrosine phosphatase inhibitors PPM1A, PTP4A1, PPP5C GLA 1088/4885GSTP1 1322/4885GSTM2 2316/4885
US-20210380582-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS PPM1A, PTP4A1, PPP5C GLA 1088/4885GSTP1 1322/4885GSTM2 2316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback